Evaluating dexamethasone intraocular suspension 9% post-cataract surgery

Video
Conferences|ASCRS

Cathleen McCabe, MD, shares an overview of results from a retrospective study highlighting the effectiveness of dexamethasone intraocular suspension 9% following cataract surgery.

Cathleen McCabe, MD, of The Eye Associates, shares an overview of results from a retrospective study highlighting the effectiveness of dexamethasone intraocular suspension 9% following cataract surgery.

Read the article highlights: Study: Dexamethasone intraocular suspension 9% offering high surgeon, patient satisfaction after cataract surgery

See more ASCRS coverage

Recent Videos
Fasika Woreta, MD, MPH, Eugene de Juan, M.D. Professor of Ophthalmic Education at Wilmer Eye Institute’s Baltimore and Columbia locations, discusses the NMA meeting
Cochair Kelly K. Nichols, OD, PhD, MPH, FAAO, highlights her passion for dry eye research and the vital collaboration between ophthalmology and optometry
Related Content
Efficacy of novel eye drop to reverse cataracts after phase 1/2 study

Efficacy of novel eye drop to reverse cataracts after phase 1/2 study

Article
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery

EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery

Podcast
University of Colorado uses simulator to upgrade cataract surgery training for ophthalmology residents

University of Colorado uses simulator to upgrade cataract surgery training for ophthalmology residents

Article
EyePod: Navigating the premium lens landscape from pipeline to practice

EyePod: Navigating the premium lens landscape from pipeline to practice

Podcast
Study examines efficacy of compound electrolyte intraocular irrigating solution

Study examines efficacy of compound electrolyte intraocular irrigating solution

Article
Richard Rosen, MD, honored with distinguished award from ASRS

Richard Rosen, MD, honored with distinguished award from ASRS

Article
© 2024 MJH Life Sciences

All rights reserved.